2197 related articles for article (PubMed ID: 28851521)
1. Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures.
Aguado-Maestro I; Panteli M; García-Alonso M; Bañuelos-Díaz A; Giannoudis PV
Injury; 2017 Dec; 48 Suppl 7():S27-S33. PubMed ID: 28851521
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.
Angthong C; Rodjanawijitkul S; Samart S; Angthong W
Acta Orthop Traumatol Turc; 2013; 47(5):318-22. PubMed ID: 24164940
[TBL] [Abstract][Full Text] [Related]
3. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
[TBL] [Abstract][Full Text] [Related]
4. Femoral cortical index: an indicator of poor bone quality in patient with hip fracture.
Feola M; Rao C; Tempesta V; Gasbarra E; Tarantino U
Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S45-50. PubMed ID: 26226860
[TBL] [Abstract][Full Text] [Related]
5. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
Modi A; Tang J; Sen S; Díez-Pérez A
Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
[TBL] [Abstract][Full Text] [Related]
6. We miss the opportunity: Pretreament of osteoporosis in a German trauma center.
Rausch V; Schwarzer A; Dietrich JW; Kaisler M; Seybold D; Vollert J; Schildhauer TA; Maier C
PLoS One; 2018; 13(11):e0207122. PubMed ID: 30418992
[TBL] [Abstract][Full Text] [Related]
7. Hip fractures in the elderly: The role of cortical bone.
Tarantino U; Rao C; Tempesta V; Gasbarra E; Feola M
Injury; 2016 Oct; 47 Suppl 4():S107-S111. PubMed ID: 27558243
[TBL] [Abstract][Full Text] [Related]
8. Utilization of osteoporosis medication after a fragility fracture among elderly Medicare beneficiaries.
Yusuf AA; Matlon TJ; Grauer A; Barron R; Chandler D; Peng Y
Arch Osteoporos; 2016 Dec; 11(1):31. PubMed ID: 27696099
[TBL] [Abstract][Full Text] [Related]
9. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
10. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
11. Managing osteoporosis in ulcerative colitis: something new?
Piodi LP; Poloni A; Ulivieri FM
World J Gastroenterol; 2014 Oct; 20(39):14087-98. PubMed ID: 25339798
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis Care Gap After Hip Fracture - Worse With Low Healthcare Access and Quality.
Galli S; Weiss D; Beck A; Scerpella T
J Clin Densitom; 2022; 25(3):424-431. PubMed ID: 34696980
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and Treatment of Osteoporosis.
O'Connor KM
Med Clin North Am; 2016 Jul; 100(4):807-26. PubMed ID: 27235616
[TBL] [Abstract][Full Text] [Related]
14. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study.
Rossini M; Viapiana O; Vitiello M; Malavolta N; La Montagna G; Maddali Bongi S; Di Munno O; Nuti R; Manzini CU; Ferri C; Bogliolo L; Mathieu A; Cantatore F; Del Puente A; Muratore M; Grassi W; Frediani B; Saviola G; Delvino P; Mirone L; Ferraccioli G; Tripi G; Piazza I; Gatti D
Reumatismo; 2017 May; 69(1):30-39. PubMed ID: 28535619
[TBL] [Abstract][Full Text] [Related]
16. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
[TBL] [Abstract][Full Text] [Related]
17. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
Aboyoussef M; Vierkoetter KR
Hawaii Med J; 2007 Jul; 66(7):185-7. PubMed ID: 17879856
[TBL] [Abstract][Full Text] [Related]
18. Who is at risk of receiving inadequate care for osteoporosis following fragility fractures? A retrospective study.
Blecher R; Wasrbrout Z; Arama Y; Kardosh R; Agar G; Mirovsky Y
Isr Med Assoc J; 2013 Oct; 15(10):634-8. PubMed ID: 24266091
[TBL] [Abstract][Full Text] [Related]
19. Management of Bone Fragility in Primary Care in Ireland.
O'Connor R; O'Regan A; O'Doherty J
Ir Med J; 2018 Jan; 111(1):674. PubMed ID: 29869855
[TBL] [Abstract][Full Text] [Related]
20. Long-term Bisphosphonates for Osteoporosis: A Factor Effecting Fracture Pattern?
Yaacobi E; Rotman Pikielny P; Kish B; Shilo Yaacobi D; Brin Y; Ohana N
Isr Med Assoc J; 2021 Aug; 23(8):497-500. PubMed ID: 34392625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
